Aduro starts Phase 1b trial of its immunotherapy treatment for lung cancer
Immunotherapy company Aduro Biotech has announced it has initiated its Phase 1b study of its ADU-214 drug in combination with nivolumab...
top of page
Entradas destacadas
Entradas recientes
Archivo
Buscar por tags
bottom of page